Details for New Drug Application (NDA): 075469
✉ Email this page to a colleague
The generic ingredient in BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE is bisoprolol fumarate; hydrochlorothiazide. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate; hydrochlorothiazide profile page.
Summary for 075469
Tradename: | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE |
Applicant: | Watson Labs Teva |
Ingredient: | bisoprolol fumarate; hydrochlorothiazide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG;6.25MG | ||||
Approval Date: | Sep 25, 2000 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG;6.25MG | ||||
Approval Date: | Sep 25, 2000 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG;6.25MG | ||||
Approval Date: | Sep 25, 2000 | TE: | RLD: | No |
Complete Access Available with Subscription